Jonathan JK Stoltman, PhD is Director of the Opioid Policy Institute. They have been an addiction scientist since 2013. Their work has appeared in leading academic journals and in the media.
Treatment in America
Much has been written about the debate performances. Let's talk a little about the policies. Naturally, the opioid policy question piqued my interest. What will you do to help Americans right now in the throes of addiction, who are struggling to get the treatment they need?
In the News
Normal Silicon Valley non-sense: Move fast and break things Health-tech version: Move fast and go broke
In the News
Lack of transparency still clouds billions in opioid settlement money going to states 4 minutes📽️ Republished by 73 Local News Outlets
In the News
In the News
'Lazarus drug' may have competition in MI Important reporting about the harmful push to get other opioid overdose formulations more widely available in Michigan. These new formulations/medications (high-dose naloxone and nalmefene) will massively harm affected community members and not reduce overdose deaths. NOTE: Naloxone has been working
Some insight into our principles and how they affect business operations
In the News
People deserve to know how this money will be spent to save lives and make our community safe for everyone.
In the News
The use of fear to push products that will hurt people instead of helping them is disgusting.
Digital Health
A must-read for those who say these privacy violations are not intentional and that these companies "mean well."
In the News
The Tate Chronicles: Dr Jonathan Stoltman, Director at the Opioid Policy Institute Great to chat with Jim Tate about our opioid addiction privacy work and the role of opioid settlement money in stemming the addiction crisis we're facing. 🔊27min listen
Digital Health
A hub for the key data related to privacy & opioid addiction treatment and recovery websites Report 2 series.
Digital Health
Mo money mo problems